Gottschlich et al. screened AML samples through single-cell RNA sequencing (sc-RNA-seq) and identified CSF1R and CD86 as potential targets; they tested CAR T-cells in AML cell lines and in patient-derived xenograft models, with promising results [57]. This evidence concerns the gene CD86 and acute myeloid leukemia.